Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression

Oncotarget (2015) - Comments
doi: 10.18632/oncotarget.4105 pubmed: 26009876 issn: 1949-2553

Haolong Li, Ning Xie, Martin E. Gleave, Xuesen Dong